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Abstract
Background: Randomized trials are essential in assessing the effects of healthcare interventions
and are a key component in systematic reviews of effectiveness. Searching for reports of
randomized trials in databases is problematic due to the absence of appropriate indexing terms
until the 1990s and inconsistent application of these indexing terms thereafter.
Objectives: The objectives of this study are to devise a search strategy for identifying reports of
randomized trials in EMBASE which are not already indexed as trials in MEDLINE and to make
these reports easily accessible by including them in the Cochrane Central Register of Controlled
Trials (CENTRAL) in The Cochrane Library, with the permission of Elsevier, the publishers of
EMBASE.
Methods: A highly sensitive search strategy was designed for EMBASE based on free-text and
thesaurus terms which occurred frequently in the titles, abstracts, EMTREE terms (or some
combination of these) of reports of trials indexed in EMBASE. This search strategy was run against
EMBASE from 1980 to 2005 (1974 to 2005 for four of the terms) and records retrieved by the
search, which were not already indexed as randomized trials in MEDLINE, were downloaded from
EMBASE, printed and read. An analysis of the language of publication was conducted for the reports
of trials published in 2005 (the most recent year completed at the time of this study).
Results: Twenty-two search terms were used (including nine which were later rejected due to
poor cumulative precision). More than a third of a million records were downloaded and scanned
and approximately 80,000 reports of trials were identified which were not already indexed as
randomized trials in MEDLINE. These are now easily identifiable in CENTRAL, in The Cochrane
Library. Cumulative sensitivity ranged from 0.1% to 60% and cumulative precision ranged from 8%
to 61%. The truncated term 'random$' identified 60% of the total number of reports of trials but
only 35% of the more than 130,000 records retrieved by this term were reports of trials. The
language analysis for the sample year 2005 indicated that of the 18,427 reports indexed as
randomized trials in MEDLINE, 959 (5%) were in languages other than English. The EMBASE search
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identified an additional 658 reports in languages other than English, of which the highest number
were in Chinese (320).
Conclusion: The results of the search to date have greatly increased access to reports of trials in
EMBASE, especially in some languages other than English. The search strategy used was subjectively
derived from a small 'gold standard' set of test records and was not validated in an independent
test set. We intend to design an objectively-derived validated search strategy using logistic
regression based on the frequency of occurrence of terms in the approximately 80,000 reports of
randomized trials identified compared with the frequency of these terms across the entire EMBASE
database.
Background
Randomized trials, involving sufficient numbers of partic-
ipants are essential to distinguish reliably between the
effects of healthcare interventions and the effects of bias
or chance. Dissemination and integration of trial results
through systematic reviews of the findings provide a basis
for informed decision-making about the effects of differ-
ent interventions. To minimize bias due to the selective
availability of data, authors of systematic reviews of
healthcare interventions need to identify as many relevant
randomized studies as possible to provide reliable evi-
dence on which to base healthcare decisions [1,2].
Variations in the journals indexed in databases indicate a
need to search more than one database to ensure optimal
coverage of the published literature both in subject scope
and language of report [3,4]. Although there is evidence
that exclusion of studies in languages other than English
from reviews might make no significant difference to the
overall estimates of the effects of treatments [5-7], some
subject areas (for example, complementary and alterna-
tive medicine) have been shown to require a more com-
prehensive selection of sources and unrestricted language
searching in order to avoid substantial bias and increase
the precision, generalizability and applicability of the
findings [6,8]. EMBASE, the Excerpta Medica database
published by Elsevier, complements MEDLINE/PubMed
by providing greater coverage of some European publica-
tions and articles written in some languages other than
English [9] as well as a broad coverage of pharmacology,
psychiatry, toxicology and alternative medicine [10].
There is some evidence of added value in searching
EMBASE, as well as MEDLINE, for studies for inclusion in
systematic reviews, as the additional studies identified
contribute to the overall findings of the review; this may
be attributed in part to the greater coverage of some lan-
guages other than English in EMBASE [11,12]. The impact
of the contribution may vary considerably – the overlap of
EMBASE and MEDLINE has been estimated to be 10% to
87% depending on the topic under investigation [13-18]
– but searchers comparing the databases have concluded
that relevant studies would be missed if only MEDLINE
were searched for studies in pharmacology [19] toxicology
[20,21], psychiatry [3], alternative medicine [13] and
other medical specialties [22-29].
Searching for reports of randomized trials presents a chal-
lenge in part because this type of study design represents
only a small proportion of all the studies included in bib-
liographic databases. It is important, therefore, to devise a
strategy which is sensitive enough to find as high a pro-
portion as possible of all the relevant trials but specific
enough not to yield vast quantities of irrelevant material,
which is time-consuming, costly to evaluate and can lead
to selection error.
Trial identification in databases is problematic for a
number of reasons. Often the methods are not adequately
described by authors in titles or abstracts and not all
records in bibliographic databases have abstracts. Sensi-
tive search strategies must, therefore, include both free
text terms (used by authors in the titles and abstracts
(where available) to describe their studies) and indexing
terms (assigned by database indexers to describe studies)
for optimal retrieval. Furthermore, suitable methodologi-
cal indexing terms for randomized trials have only been
introduced relatively recently and have not always been
consistently applied. For example, in 1991, the United
States National Library of Medicine introduced into
MEDLINE the Publication Type 'Randomized Controlled
Trial' as an indexing term to improve searching for trials.
Despite this, a study by one of the authors (CL) [30]
found that over 400 reports of randomized controlled tri-
als indexed in the first six months of MEDLINE in 1993
were not coded with the new indexing term despite hav-
ing the word random (or a variation of it such as rand-
omized) in the title or abstract. A systematic review [31]
found that it was possible to identify on average only 75%
of randomized studies known to be indexed in MEDLINE.
As a consequence, a highly sensitive search strategy was
designed by one of the authors (CL) [31] to conduct The
Cochrane Collaboration's systematic search of MEDLINE
to identify reports of all definite or possible randomized
or quasi-randomized trials not already indexed as rand-
omized trials in MEDLINE, to be re-tagged in MEDLINE
with the appropriate Publication Type term. Over 100,000Emerging Themes in Epidemiology 2008, 5:13 http://www.ete-online.com/content/5/1/13
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additional reports of randomized trials have been identi-
fied in MEDLINE back to 1966 through this electronic
search, begun in 1994 by the UK Cochrane Centre and
continued by the US Cochrane Center (formerly the New
England Cochrane Center, which was formerly the Balti-
more Cochrane Center) [32,33].
Identifying reports of trials in EMBASE has proved to be
similarly problematic. Discussions began between one of
the authors (CL) and Elsevier, the producers of EMBASE,
in 1992, immediately after the UK Cochrane Centre
opened. This led to a representative from Elsevier being
invited to a workshop in January 1993, convened by the
UK Cochrane Centre. It was confirmed that although the
EMBASE thesaurus (EMTREE) contained terms for clinical
trials in general, it had no specific term for indexing
reports of randomized controlled trials. Elsevier was per-
suaded of the importance of accurate indexing of clinical
trials and of the necessity to differentiate randomized con-
trolled trials from other clinical trials. In September 1993,
Elsevier introduced the indexing term 'Randomized Con-
trolled Trial' in EMBASE together with the term 'Multi-
center Study' and undertook to index clinical trials "even
more consistently" in the future [34].
The EMBASE data structure and licensing agreements with
third party vendors such as Dialog and Ovid did not, at
that time, support record changes in the same way that
MEDLINE did and, therefore, 're-tagging' records in
EMBASE was not feasible. In addition, because The
Cochrane Collaboration did not have its own register of
trials at that time no further progress was made with
respect to making EMBASE reports of trials available cen-
trally within the Collaboration.
In mid-1996, however, as a result of the introduction by
Elsevier of a new database platform, it became possible for
them to investigate systems for updating their databases
in a way that had not previously been possible. Specifi-
cally this meant that they could consider upgrading the
indexing of EMBASE records by retrospectively adding
their new indexing term 'Randomized Controlled Trial' to
all those reports identified as such in EMBASE, thus
improving retrieval in the future.
From The Cochrane Collaboration's point of view, the
advent of the Cochrane Controlled Trials Register, now
known as the Cochrane Central Register of Controlled Tri-
als (CENTRAL), designed and developed by the then pub-
lishers of The Cochrane Library, Update Software, meant
that there was now a register within the Collaboration
which could provide a vehicle for making these reports
accessible.
In December 1996, Elsevier requested a further meeting
with one of the authors (CL) and the Managing Director
of Update Software and agreed to permit the re-publica-
tion of EMBASE records in CENTRAL. Until 1996, The
Cochrane Collaboration had focussed on the systematic
electronic searching of MEDLINE and the systematic
handsearching of general and specialized healthcare jour-
nals to facilitate access to reports of randomized trials of
healthcare interventions. With the developments
described above it was possible to extend this searching to
include EMBASE.
It was decided that a search strategy to identify reports of
randomized trials in EMBASE would be devised by two of
the authors (CL and SM) [35] from an analysis of how fre-
quently terms were used in EMBASE records to describe
reports of randomized trials, that had been identified by
handsearching the BMJ and the Lancet for the years 1990
and 1994 and that records of reports of randomized trials
identified by using this search strategy would be pub-
lished in CENTRAL.
Objectives
The objectives of this study are:
1. To devise a search strategy, tested for sensitivity and pre-
cision, for identifying reports of randomized trials in
EMBASE.
2. To identify reports of randomized trials in EMBASE that
meet the Cochrane eligibility criteria [36].
3. To identify in EMBASE reports of trials not currently
indexed as trials in MEDLINE, as these are already
included in CENTRAL.
4. To make these reports easily accessible by including
them in CENTRAL in The Cochrane Library, with the per-
mission of Elsevier, the publishers of EMBASE.
Methods
Identifying initial search terms for testing
The Medical Subject Headings (MeSH) and Publication
Type terms from the Cochrane Highly Sensitive Search
Strategy for identifying reports of randomized trials in
MEDLINE [31] were converted (where possible) into suit-
able terms from the EMBASE thesaurus, EMTREE. For
example, the MeSH term 'Double-blind-Method' in
MEDLINE was converted to the EMTREE term 'Double-
blind Procedure'. In addition, EMTREE was examined
carefully to identify additional likely candidate terms.
Free-text terms were selected, including those included in
the Cochrane Highly Sensitive Search Strategy for rand-
omized trials [31] and finally, members of The Cochrane
Collaboration, including those involved in devisingEmerging Themes in Epidemiology 2008, 5:13 http://www.ete-online.com/content/5/1/13
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search strategies to populate the Cochrane Review
Groups' Specialized Registers of studies potentially rele-
vant for systematic reviews, and other information spe-
cialists outside the Collaboration known to have worked
on devising similar search strategies, were consulted for
further suggestions.
Creating the 'gold standard' set of EMBASE records
To test the sensitivity and precision of the search terms
resulting from the above activities, a 'gold standard' set of
reports of randomized controlled trials was established
from the results of handsearching two general healthcare
journals, the BMJ and the Lancet, for 1990 and 1994 for all
reports of randomized or quasi-randomized trials. These
journals had already been handsearched under another
project co-ordinated by two of the authors (CL and SM) at
the UK Cochrane Centre and funded by the European
Union under the BIOMED Programme [37]. The inten-
tion was to create separate sensitivity and precision figures
for 1990 and 1994, in order to evaluate the impact of the
introduction in EMBASE in 1993 of the indexing term
'Randomized Controlled Trial' and the impact of any
changes in indexing that might have arisen due to Else-
vier's intention to index randomized trials "even more
consistently", announced in March 1994 [34].
Two data sets were created for each of the two years. The
first set, the 'gold standard' set, contained the correspond-
ing EMBASE records for each of the reports of trials in the
BMJ and the Lancet published in 1990 (n = 191) and 1994
(n = 193) found by the handsearch. The second set, the
'full EMBASE' data set, contained all BMJ  and  Lancet
records indexed in EMBASE for the years 1990 (n = 6207)
and 1994 (n = 4730).
Testing the search terms for sensitivity and precision
Sensitivity is defined as the number of reports of rand-
omized trials identified by the search term divided by the
total number of reports of randomized trials identified,
expressed as a percentage. Precision (positive predictive
value) is defined as the number of reports of randomized
trials identified by the search term divided by the total
number of records retrieved, expressed as a percentage.
Each of the search terms under consideration was
searched for in the 'gold standard' set to identify how
many of the reports each term identified (to calculate the
sensitivity) and in the 'full EMBASE' set to identify how
many records in total each term retrieved (to calculate the
precision) for the year 1990 (Table 1) and 1994 (Table 2).
Developing, refining and executing the search strategy
Search terms with both a precision of over 40% and a sen-
sitivity of over 1% in either 1990 or 1994 were selected for
further evaluation together with the terms follow-up, fol-
lowup or follow up, volunteer$ and the descriptor term
Randomization, which had not been tested in the original
analysis (Table 3) [35]. The search terms included free-text
terms, used in the title and/or abstract of articles to
describe the study being reported and EMTREE terms
assigned by the database indexers to describe the report.
The systematic search was conducted as a multi-file search
across MEDLINE and EMBASE so that duplicate records in
EMBASE indexed in MEDLINE with the Publication Type
'Randomized Controlled Trial' or 'Controlled Clinical
Trial' could be removed first before downloading records
Table 1: Sensitivity and precision of terms from trial reports in 
the BMJ and Lancet in 1990.
Sensitivity % Precision %
random* 48 64
Major Clinical Study (EMTAG 0150) 42 19
Controlled Study (EMTAG 0197) 37 34
trial* 36 52
control* 34 29
study 30 22
compar* 29 24
Clinical Article (EMTAG 0152) 29 13
placebo* 25 88
blind* 23 76
doubl* 23 79
clinic* 21 16
Clinical Trial (DR) 15 53
follow* and up 15 26
Controlled Study (DE) 12 36
prospectiv* 12 23
allocat* 11 88
versus 8 45
Double-blind Procedure (DE) 7 93
Drug Comparison (DR) 7 22
vs 7 35
crossover*/cross-over* 6 100
Placebo (DE) 5 56
Major Clinical Study (DE) 5 15
Follow-up (DE) 5 13
assign* 4 73
singl* 4 16
studies 4 15
Prospective Study (DE) 3 31
Clinical Trial (DE) 3 13
volunteer* 2 25
factorial* 2 100
Comparison (DE) 1 20
mask* 1 18
tripl* 0.5 50
Clinical Study (DE) 0.5 50
longitudinal* 0.5 17
Longitudinal Study (DE) 0.5 33
The '*' denotes a free-text term with variant endings, used in the title 
or abstract of articles to describe the study being reported, e.g. 
random* will retrieve random, randomize, randomise, randomisation 
etc. EMTAG, DE and DR denote EMTREE descriptor terms.Emerging Themes in Epidemiology 2008, 5:13 http://www.ete-online.com/content/5/1/13
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unique to EMBASE for each term sequentially to be
checked for eligibility.
The search terms were executed sequentially so that the
incremental (cumulative) value of each term could be
assessed. Cumulative sensitivity is defined as the addi-
tional number of reports of randomized trials identified
by each term when searched in its position in the search
sequence divided by the total number of reports of rand-
omized trials identified, expressed as a percentage. Cumu-
lative precision (positive predictive value) is defined as
the additional number of reports of randomized trials
identified by each term when searched in its position in
the search sequence divided by the total number of
records retrieved by that term, expressed as a percentage.
Terms with low cumulative precision were rejected. Each
potentially relevant record was, therefore, only retrieved
once, even if it contained more than one of the terms in
the search strategy. For example, a record containing the
phrase 'randomized placebo controlled trial' would be
identified by the first search term 'random$' but would be
excluded from the set derived by the search term 'pla-
cebo$' (Table 4). The order of the terms in the sequential
strategy was based on the sensitivity and precision in the
1990 search results (Table 1). The systematic search was
run in two phases: (i) during 1997 and 1998, using the
first four search terms, and (ii) from 1999 onwards using
22 terms, nine of which were later rejected because of low
cumulative precision. The first four terms to be searched
were 'random$', 'factorial', 'crossover$ or cross-over$' and
'placebo$'. Random$ and placebo$ were selected to be
searched as they had relatively high sensitivity (48% and
25%, respectively) but also had relatively high precision
(64% and 88%, respectively) and generated large num-
bers of records. Crossover$/cross-over$ and factorial$
were also selected as they were the only terms in the 1990
data set test sample that achieved 100% precision.
Table 2: Sensitivity and precision of terms from trial reports in 
the BMJ and Lancet in 1994.
Sensitivity % Precision %
Controlled Study (EMTAG 0197) 83 20
Controlled Study (DE) 77 19
Clinical Trial (DE) 62 17
Major Clinical Study (DE) 58 17
Major Clinical Study (EMTAG 0150) 58 17
random* 57 59
Randomized Controlled Trial (DE) 55 69
trial* 47 48
compar* 39 34
control* 36 29
study 32 23
follow* and up 22 34
clinic* 22 15
blind* 21 71
Double-blind Procedure (DE) 19 86
placebo* 19 73
Clinical Trial (DR) 18 41
Clinical Article (EMTAG 0152) 18 10
Clinical Article (DE) 18 10
Placebo (DR) 17 56
doubl* 17 75
Follow-up (DE) 15 24
vs 14 47
Multicenter Study (DE) 12 65
assign* 11 73
prospectiv* 11 23
allocat* 10 57
versus 10 41
Drug Comparison (DR) 10 40
singl* 7 31
studies 6 14
crossover*/cross-over* 4 100
Crossover Procedure (DE) 4 89
Comparison (DE) 3 25
Phase 3 Clinical Trial (DE) 2 75
Intermethod Comparison (DE) 2 50
volunteer* 2 30
Single-blind Procedure (DE) 1 50
factorial* 1 100
longitudinal* 1 25
Prospective Study (DE) 1 18
The '*' denotes a free-text term with variant endings, used in the title 
or abstract of articles to describe the study being reported, e.g. 
random* will retrieve random, randomize, randomise, randomisation 
etc. EMTAG, DE and DR denote EMTREE descriptor terms
Table 3: Search terms evaluated for systematic search of 
EMBASE in sequential order.
random$
factorial$
crossover$ or cross-over$
placebo$
doubl$ adj blind$
singl$ adj blind$
assign$
allocat$
volunteer$
Crossover Procedure.sh.
Double-blind Procedure.sh.
Randomized Controlled Trial.sh.
Single-blind Procedure.sh.
versus
follow-up or follow up or followup
Phase 3 Clinical Trial.sh.
Intermethod Comparison.sh.
Multicenter Study.sh.
Placebo.sh.
Randomization.sh.
trial$
vs
The '$' denotes a free-text term with variant endings, used in the title 
or abstract of articles to describe the study being reported, e.g. 
random$ will retrieve random, randomize, randomise, randomisation 
etc. The '.sh.' denotes an index term (EMTREE) assigned by the 
EMBASE indexers to describe the report.Emerging Themes in Epidemiology 2008, 5:13 http://www.ete-online.com/content/5/1/13
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Some search terms, as a result of their position in the
sequence, had a cumulative precision of less than 10% in
sample years (1980, 1985, 1990, 1995, and 1998) and
these terms were not then used to complete the systematic
search in all years (Table 5).
Removing duplicates
Online database providers (firstly DataStar, then Dialog
and then Ovid) offering the ability to search MEDLINE
and EMBASE simultaneously were used to identify and
download records from EMBASE so that records which
were already indexed with the Publication Type terms
'Randomized Controlled Trial' or 'Controlled Clinical
Trial' in MEDLINE (and were, therefore, already included
in CENTRAL) could be excluded by the EMBASE search.
Initially, we used DataStar as the search interface of choice
but this was limited at that time to de-duplicating 3000
records. As there were many more than 3000 records
retrieved by our search sets across MEDLINE and EMBASE
combined this meant that de-duplication was extremely
tedious. We changed to Dialog to increase the limit to
5000 records and eventually changed to Ovid in 1999.
Both DataStar and Dialog provided access to EMBASE
back to 1974 but Ovid at that time only provided access
Table 4: Sequential search in EMBASE – publication years 1974–2005 (first four terms) and 1980–2005 (other terms).
Search terms Number of records retrieved by each search term
1r a n d o m $ 130875
2 factorial$ not 1 3342
3 (crossover$ or cross-over$) not (1 or 2) 6348
4 placebo$ not (1 or 2 or 3) 36751
5 (doubl$ adj blind$) not (1 or 2 or 3 or 4) 6846
6 (singl$ adj blind$) not (1 or 2 or 3 or 4 or 5) 691
7 assign$ not (1 or 2 or 3 or 4 or 5 or 6) 22148
8 allocat$ not (1 or 2 or 3 or 4 or 5 or 6 or 7) 7097
9 volunteer$ not (1 or 2 or 3 or 4 or 5 or 6 or 7 or 8) 57510
10 Crossover Procedure.sh. not (1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9) 1758
11 Double-blind Procedure.sh. not (1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10) 5945
12 Randomized Controlled Trial.sh. not 
(1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11)
11619
13 Single-blind Procedure.sh. not 
(1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12)
612
TOTAL 291542
Table 5: Search results for terms rejected due to low cumulative precision in sample years in EMBASE.
Search terms in sequential 
order
No. of additional reports of 
trials identified/total no. of 
additional records 
retrieved per search term 
(for sample years)
Cumulative precision (%) 
(no. of additional reports 
of trials identified/total no. 
of additional records 
retrieved) 
(for sample years)
No. of additional reports of 
trials identified/total no. of 
additional reports of trials 
identified 
(for sample years)
Cumulative sensitivity (%) 
(no. of additional reports 
of trials identified/total no. 
of reports of trials 
identified) 
(for sample years)
versus 698/9163 8 698/3965 18
followup or follow up 191/8041 2 191/1519 15
Phase 3 Clinical Trial.sh. 19/398 5 19/2877 0.7
Intermethod 
Comparison.sh.
165/3473 5 165/3745 4.4
Multicenter Study.sh. 92/1790 5 92/2048 4.4
Placebo.sh. 178/2633 7 178/4364 4
Randomization.sh. 16/511 3 16/26972 0.1
trial$ 979/11331 9 979/4771 21
vs 693/8666 8 693/4485 15
TOTALS 3031/46006 7
These search terms were rejected after evaluation for the systematic search of EMBASE due to low cumulative precision (< 10%) in the sample 
years (1980, 1985, 1990, 1995, 1998). When terms for the systematic search were evaluated these terms were executed lower in the sequential 
search and therefore would be expected to have low cumulative precision as they only searched the set of records not yet identified by any of the 
other terms listed higher in the strategy.Emerging Themes in Epidemiology 2008, 5:13 http://www.ete-online.com/content/5/1/13
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back to 1980. This change meant that the remainder of the
terms could not be searched back to 1974 but only back
to 1980.
Downloading and scanning
Records were downloaded and printed for the publication
years 1974–2005 for the first four terms (random$, facto-
rial$, crossover$ or cross-over$, placebo$) and
1980–2005 for the remainder (Table 4).
The title and abstract of each record was read by a trained
handsearcher to identify reports of definite or possible
randomized or quasi-randomized controlled trials meet-
ing the Cochrane eligibility criteria [36]. All records were
checked by a second, experienced handsearcher. Any dis-
agreements were resolved by a third person with further
reference to a clinical trialist where necessary. Records
were then transferred into reference management software
(ProCite) for transfer to Update Software Ltd., and latterly
to John Wiley & Sons, Ltd/Wiley-Blackwell, publishers of
The Cochrane Library, for inclusion in CENTRAL.
Language analysis
Reports of controlled trials in EMBASE identified in our
study with the publication year 2005 were analysed
according to language of publication. A comparison was
made with reports of trials for the year 2005 and indexed
with the Publication Type 'Randomized Controlled Trial'
or 'Controlled Clinical Trial' in MEDLINE (Figure 1).
Results
The sensitivity rankings for the search terms based on
reports of trials identified from the handsearching of the
BMJ and the Lancet differ from 1990 to 1994. In 1990, no
EMTREE term has a sensitivity of over 50% compared
with four EMTREE terms in 1994 (Tables 1 and 2). The
increase in sensitivity of EMTREE terms in 1994 compared
with 1990 indicates that Elsevier were indexing clinical tri-
als more consistently in the later year.
Trial reports in MEDLINE and additional trial reports in EMBASE in 2005 in non-English languages Figure 1
Trial reports in MEDLINE and additional trial reports in EMBASE in 2005 in non-English languages. This figure 
shows reports indexed with the Publication Type 'Randomized Controlled Trial' or 'Controlled Clinical Trial' in MEDLINE and 
additional reports of trials identified in EMBASE, published in 2005 in languages other than English. The reports indexed in 
MEDLINE include reports identified in both MEDLINE and EMBASE. The additional reports in EMBASE, therefore, indicate the 
added value of searching EMBASE as well as searching MEDLINE.
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During 1997 and 1998, 30,000 reports of trials were iden-
tified from 90,000 records downloaded from EMBASE
from 1974 to 1997, using the first four search terms [9]
(Table 4). Since then, a further 36,000 reports of trials
have been identified from 200,000 records downloaded
from EMBASE from 1980 to 2003 using 22 terms, nine of
which were later rejected because of low cumulative preci-
sion (< 10%) [38] (Tables 5 and 6). During 2004 and
2005, an additional 12,000 reports of trials have been
identified from 48,000 records downloaded using 13
terms (Table 6).
Cumulative sensitivity ranged from 0.1% to 60% and only
three terms achieved a cumulative sensitivity of 10% or
more: random$ (60%), placebo$ (12%) and volunteer$
(10%) (Table 6). Cumulative precision ranged from 8%
to 61% with three terms at less than 10%: factorial$ (9%),
Double-blind Procedure (9%) and assign$ (8%) (Table
6).
The first term 'random$' generated the most records
(130,875) of which 35% were found to be reports of con-
trolled trials and contributed the greatest proportion of
the total number of reports of trials identified (60%)
(Table 6). The phrase 'doubl$ adj blind$' generated 6846
additional records, just over 60% of which were deemed
to be reports of controlled trials. The phrase 'singl$ adj
blind$' only generated 691 additional records, 45% of
which were deemed to be reports of controlled trials. The
term 'placebo$' generated 36,751 additional records, 25%
of which were deemed to be reports of controlled trials
and was the second largest contributor to the total
number of reports of trials identified (12%). The term
'volunteer$' generated the second highest number of addi-
tional records (57,510), only 13% of which were deemed
to be reports of trials. It contributed the third highest pro-
portion of the total number of reports of trials identified
(10%). The term 'assign$' generated 22,148 additional
records, only 8% of which were deemed to be reports of
trials. The index term 'Randomized Controlled Trial' gave
a relatively low cumulative precision (14%) which partly
reflects its penultimate position in the sequential strategy
but also reflects the use of this term to index articles which
report a randomized controlled trial but also articles
which discuss randomized controlled trials from a meth-
odological or study design aspect which would not be rel-
evant for inclusion in CENTRAL.
In total (including results from the search terms later
rejected due to low cumulative precision) approximately
350,000 records have been downloaded from EMBASE
and records for all of the approximately 80,000 reports of
randomized trials unique to EMBASE at the time of the
searches (i.e. not also indexed as controlled trials in
MEDLINE) are included in CENTRAL in The Cochrane
Library.
Table 6: Search results for terms selected to search EMBASE (1974–2005 first four terms; 1980–2005 other terms).
Search terms in sequential order No. of additional reports of trials 
identified/total no. of additional 
records retrieved per search term
Cumulative precision (%) (no. of 
additional reports of trials 
identified/total no. of additional 
records retrieved)
Cumulative sensitivity (%) (no. of 
additional reports of trials 
identified/total no. of reports of 
trials identified) (n = 75,152)
random$ 45458/130875 35 60
factorial$ 309/3342 90 . 4
crossover$ or cross-over$ 3304/6348 52 4.4
placebo$ 9224/36751 25 12
doubl$ adj blind$ 4170/6846 61 6
singl$ adj blind$ 309/691 45 0.4
assign$ 1709/22148 82 . 3
allocat$ 725/7097 10 1
volunteer$ 7496/57510 13 10
Crossover Procedure.sh. 266*/1758 15 0.4
Double-blind Procedure.sh. 524/5945 90 . 7
Randomized Controlled 
Trial.sh.
1593**/11619 14 2
Single-blind Procedure.sh. 65*/612 11 0.1
TOTALS 75152/291542 26
When terms for the systematic search were evaluated the terms executed lower in the sequential search would be expected to have low 
cumulative precision as they only searched the set of records not yet identified by any of the other terms listed higher in the strategy.
* The search terms Crossover Procedure.sh. and Single-blind Procedure.sh. were introduced in 1987 and so this figure represents the total number 
of reports of trials identified for the publication years 1987–2005 only.
** The search term Randomized Controlled Trial.sh. was introduced in 1993 and so this figure represents the total number of reports of trials 
identified for the publication years 1993–2005 only.Emerging Themes in Epidemiology 2008, 5:13 http://www.ete-online.com/content/5/1/13
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The results of the language analysis indicate that for the
publication year 2005 searching EMBASE did not identify
any more reports of trials in Croatian, Hungarian, Lithua-
nian, Romanian or Russian than those already found in
MEDLINE (Figure 1). Searching EMBASE also did not
identify many more reports of trials in Bulgarian (1),
Czech (5), Danish (4), Greek (1), Hebrew (1), Korean (5),
Norwegian (2), Serbian (1) or Slovak (3) than those
already found in MEDLINE. However 320 reports of trials
in Chinese were identified in EMBASE in addition to the
257 already identified in MEDLINE. The reports of trials
in Persian (Farsi) (6) were only identified in EMBASE. The
additional reports of trials in EMBASE in Dutch (13), Ital-
ian (15) and Turkish (50) were more than those identified
in MEDLINE (3, 11 and 12 respectively). Of the 18,427
reports of trials in MEDLINE with the Publication Type
'Randomized Controlled Trial' or 'Controlled Clinical
Trial' published in 2005, 959 (5%) are reports in lan-
guages other than English. Of the 8464 additional reports
of trials identified in EMBASE (after de-duplication of
records matching reports indexed as randomized trials in
MEDLINE), 658 (8%) are reports in languages other than
English.
Discussion
Projects such as this and the systematic electronic search
of other bibliographic databases such as MEDLINE tend
to under-identify reports of trials as there is often insuffi-
cient evidence in the title or abstract of a record to assess
adequately whether it is a report of a randomized trial
even if it is clearly stated in the methods section of the full
journal article. In a recent study, 20 (7%) additional
reports of randomized controlled trials were identified
only by obtaining the full text of the article [39]. To iden-
tify these reports of trials it is necessary to handsearch the
journal [1] or to read the full text of articles retrieved by
terms in the search strategy or found by other means.
In addition, further reports of trials could have been iden-
tified from EMBASE by using terms with lower cumulative
precision. Whilst including these terms was not consid-
ered to be feasible in the context of the project that aimed
to search the whole of EMBASE, they could be considered
by searchers who would be combining their study design
search terms with subject- or condition-specific search
terms in EMBASE and would thus retrieve considerably
fewer records for consideration.
Records were de-duplicated within the host system rather
than within reference management software. Any use of
de-duplication facilities, either within the host system or
using reference management software, may lead to over-
and/or under-inclusion of records. No systematic quality
control of the de-duplication process was undertaken but
ad hoc viewing of the duplicate pairs seemed to indicate
that the duplicates identified by the host system were
valid duplicates. The eligibility criteria for including
reports of trials in CENTRAL state that records should be
included if they are 'definitely or possibly a report of a ran-
domized or quasi-randomized trial'. Benefit of the doubt
is, therefore, exercised where necessary. It should, how-
ever, be noted that some reports which claim to be reports
of randomized trials in the title or abstract are not in fact
randomized trials on the basis of further details given in
the Methods section and such reports will have been
included erroneously in CENTRAL as a result of this
project and other similar projects where records are iden-
tified on the basis of the title and abstract only [40].
Many methodological search strategies or 'filters' have
been developed in MEDLINE to make it easier to find
studies of systematic reviews [41-44] and randomized
controlled trials [31,36,45-62] and, more recently, in
EMBASE [63,64]. The study by Wong and colleagues [63]
is the only study (other than this study) of which we are
aware to develop a strategy to detect 'clinically sound'
treatment studies in EMBASE.
Since 1996 when the search strategy reported here was
derived, methods of search strategy design have devel-
oped from subjectively derived strategies that were not
performance tested [31] to subjectively derived strategies
performance tested on data sets of relevant reports
[58,63,65], such as this strategy, and objectively derived
strategies, performance tested on such data sets
[36,41,43,61]. The analysis used in 1996 to derive the
terms for this EMBASE systematic search manifests a
number of limitations which we intend to address in the
final phase of this search strategy development. The 1996
analysis was based on a small data set (400 records of
reports of trials) in two years (1990 and 1994) from two
general healthcare journals (the BMJ and the Lancet) and
the terms were derived subjectively.
The extent to which the derived search strategy is general-
izable depends upon the sample of journals in the 'gold
standard'. Boynton and colleagues have warned that the
journals used in such 'gold standards' may not be repre-
sentative of healthcare journals as a whole [41]. Further-
more, it has been suggested that higher impact factor
journals may demand a higher standard of reporting
which might bias the retrieval effectiveness of the filter
when used for lower impact factor journals [43]. The BMJ
and Lancet, which were used to derive the search terms in
1996, are general medical journals with medium to high
impact factors, published in English.
Whether a filter developed and tested in two separate
years (in this study 1990 and 1994) will give the same
results for other years is likely to be affected by additionsEmerging Themes in Epidemiology 2008, 5:13 http://www.ete-online.com/content/5/1/13
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and amendments to index terms over time. Although
Wilczynski and colleagues established the robustness of
search strategies across publication periods 1991 and
2000 in MEDLINE [66] which led to the decision by
Wong and colleagues to confine their handsearch to the
year 2000 in EMBASE [63], it is not clear whether a similar
robustness is present in EMBASE.
The validation of a search filter is important in assessing
the effectiveness of the filter outside the set used for deriv-
ing and testing it. If the same data set is used for both pur-
poses it has been suggested that it can introduce bias
resulting in an overestimate of the effectiveness of the fil-
ter [41] because a strategy will tend to perform better on
the set of records from which it was derived [43]. Wong
and colleagues [63] chose not to divide their 'gold stand-
ard' into a test set (used for deriving the search filter) and
a validation set (used for testing it) for their EMBASE strat-
egies but developed and tested the strategies using the
whole data set, consisting of nearly 28,000 articles. This is
because their MEDLINE study [58] found that strategies
developed in 60% of the data set and validated in the
remaining 40% showed no statistical differences in per-
formance.
Other initiatives, in particular the CONSORT Statement,
aimed at improving the reporting of trials by authors may
well have facilitated their retrieval in databases over time.
CONSORT was introduced in 1996 [67] and revised in
2001 [68]. It is a checklist of 22 items and a flow diagram
designed to help improve the consistency and quality of
reporting of randomized controlled trials and includes a
specific recommendation to identify the report as a rand-
omized trial in the title. It has been endorsed by key
healthcare journals. There is evidence that there has been
an increase over time in the number of checklist items
included in reports of randomized trials [69-71] which
has led to reports of trials being more easily identified
[59]. The CONSORT initiative was further enhanced by
the publication in January 2008 of CONSORT for
Abstracts which includes a checklist of 17 items designed
to improve the consistency and quality of reporting of
randomized trials in conference abstracts and abstracts in
journal articles [72,73].
In recent years, the Centre for Reviews and Dissemination
and the UK Cochrane Centre have sought to improve the
objectivity of the methods used to design search strategies.
They have used word frequency analysis and discriminant
analysis to derive objectively, using logistic regression, the
most efficient search terms and combinations of terms in
titles, abstracts and index terms for particular study
designs. The Group's most recent research in this area
[36,61] presents a series of MEDLINE strategies with vary-
ing levels of sensitivity and precision designed to retrieve
reports of randomized trials. We intend to develop this
work further to complete the final phase of search strategy
development to identify reports of randomized trials in
EMBASE using this objective method with logistic regres-
sion and making use of the whole data set of approxi-
mately 80,000 reports of trials identified to date in the
initial systematic search of EMBASE reported here.
Conclusion
Searching EMBASE for reports of randomized trials and
ensuring that they are made available in CENTRAL in The
Cochrane Library have enhanced access to reports of trials,
especially those published in languages other than Eng-
lish. This project has made it easier to identify approxi-
mately 80,000 reports of randomized trials by identifying
the relevant records in EMBASE and including these, with
the permission of Elsevier, in the Cochrane Central Regis-
ter of Controlled Trials in The Cochrane Library. We have
also identified terms that might be useful to people
searching EMBASE for randomized trials in the future.
However, further work remains to be done to address the
limitations in the search strategy reported in this study.
We intend to perform an objective analysis, using logistic
regression, of the frequency of terms occurring in the
approximately 80,000 reports of trials that have been
identified to date, compared with their frequency across
the entire EMBASE database. The results of this final anal-
ysis will be used to generate a highly sensitive search strat-
egy for EMBASE to make reports of trials accessible to
authors of reviews and others interested in basing health-
care decisions on the best available evidence.
Key messages
EMBASE is a rich source of reports of randomized trials
that are either not included in MEDLINE or not indexed
as trials in MEDLINE, especially reports in some languages
other than English.
Due to this project, approximately 80,000 reports of ran-
domized trials are now more accessible through the inclu-
sion of relevant records in the Cochrane Central Register
of Controlled Trials (CENTRAL) in The Cochrane Library.
In addition to searching CENTRAL, people looking for
reports of randomized trials should search EMBASE, as
well as MEDLINE, for reports published in recent years
that have not yet been considered for inclusion in CEN-
TRAL.
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